Biotie Therapies Expands CNS Pipeline with Acquisition of Synosia Therapeutics
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 1 (Table of Contents)
Published: 31 Jan-2011
DOI: 10.3833/pdr.v2011.i1.1425 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In an effort to establish itself as a leading CNS drug development company, Biotie Therapies has agreed to acquire Synosia Therapeutics in an all-share deal valued at €93...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS